B. Feagan

Statistics

Publications

Citations

136

H-Index

Active since

1998

Affiliations

Robarts Clinical Trials(Current)

B. Feagan is an author at Robarts Clinical Trials specializing in inflammatory bowel disease, inflammatory bowel disease therapy, and clinical sciences.

Publications per year

1998–2016

Publications

The ideal management of Crohn's disease: Top down versus step up strategies, a randomized controlled trial

DW Hommes, Filip Baert, Gert Van Assche et al. · Ghent University Academic Bibliography (Ghent University) · 2006 · 45 citations

Medicine, Clinical Sciences, Internal Medicine +8

A randomized controlled trial evaluating the ideal medical management for Crohn's disease (CD): Top-down versus step-up strategies

DW Hommes, Filip Baert, Gert Van Assche et al. · Ghent University Academic Bibliography (Ghent University) · 2005 · 35 citations

Medicine, Clinical Sciences, Internal Medicine +11

Safety of Infliximab and Other Crohnʼs Disease Therapies

Gary R. Lichtenstein, Roni Cohen, B. Feagan et al. · The American Journal of Gastroenterology · 2008 · 22 citations

Pharmacy, Internal Medicine, Pharmacotherapy +12

11 Vedolizumab induction therapy for patients with Crohn's disease and prior anti-tumour necrosis factor antagonist failure: a randomised, placebo-controlled, double-blind, multicentre trial

B E Sands, B. Feagan, P. Rutgeerts et al. · Journal of Crohn s and Colitis · 2013 · 13 citations · Full text

Life Sciences, Immunology, Microbiology +17

OC-057 A PH3 Randomised, Multicenter, Double-Blind, Placebo (PBO)-Controlled Study of Ustekinumab (UST) Maintenance Therapy in Moderate–Severe Crohn’s Disease (CD) PTS: Results from IM-UNITI

WJ Sandborn, B. Feagan, C Gasink et al. · 2016 · 11 citations

Medicine, Clinical Sciences, Pharmacotherapy +15

1–5 of 6